Go to article
Posted by Peter on 12-27 4:31 am
Tags: 3D micro-structures found in biological tissue, 3D printed life-like liver tissue, 3D printed tissue, approval for a drug, bioprinting tech in the lab capable of reproducing the elements and features of the tissue. drug screening tool for pharmaceutical companies, cancer, cirrhosis, diverse combination of liver cells and supporting cells systematically organized in a hexagonal, drug to market, drugs don’t pass animal tests or human clinical trials, eliminate drugs that have less efficacy, engineers, FDA, Federal Drug Administration, focus on drugs that appear to be more promising, hepatitis, lack both the complex micro-architecture and diverse cell makeup of a real liver, liver models are increasingly being developed in the lab as platforms for drug screening, liver tissue that mimics real human liver tissue, metabolizes drugs, patient-specific organ printing in the future. in vitro disease models, Pharmaceutical companies, platform for drug screening, platform in the lab, produces key proteins, simulates how the human liver functions and is structured, University of California
Categories:
General
Innovation
Research
The Industry
